Clinimix 230 mg (l-Valine SOLUTION) 230 MG

Clinimix 230 mg is an intravenous solution containing L-Valine, designed to support nutritional needs. This product is manufactured by Baxter Corporation in Canada and is available in a 1000ml pack size.

Strength

230 MG

Pack Size

1000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clinimix 230 mg is used to provide essential amino acids, including L-Valine, to patients who cannot meet their nutritional needs through oral intake. It is often used in clinical settings to support protein synthesis and overall health in patients requiring intravenous nutrition. What is Clinimix 230 mg used for? It is primarily used for nutritional support in patients who need intravenous nutrition.

Side Effects

Clinimix 230 mg may help improve nutritional status by providing essential amino acids. Patients may experience improved energy levels and overall well-being when used as directed. Common effects include better nutrient absorption and support for muscle maintenance.

Precautions & Warnings

Clinimix 230 mg should be administered under medical supervision. It is important to follow proper handling and storage guidelines to ensure safety. Patients with certain medical conditions should consult their healthcare provider before use.

Avoid Interactions

Clinimix 230 mg may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Avoid mixing with other solutions unless directed by a healthcare professional.

Frequently Asked Questions

Clinimix 230 mg is used to provide essential amino acids, including L-Valine, to support nutritional needs in patients who cannot consume food orally.

Clinimix 230 mg is administered intravenously, typically in a clinical setting under medical supervision.

Common effects include improved nutrient absorption and support for muscle maintenance, contributing to overall well-being.

Yes, it should be administered under medical supervision and proper handling and storage guidelines should be followed.

Yes, it may interact with other medications or supplements, so it is important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.